A. Gilles, B. Pharmacie-clinique-alain, B. Jean-claude, C. Santé-publique-christine, F. Pharmacologie-cardiovasculaire-chantal et al., Chimie physique générale, Biologie cellulaire oncologique Jean-Bernard REGNOUF de VAINS ........ Chimie thérapeutique Bertrand RIHN ................................... Biochimie, Biologie

B. Sandrine, B. Mariette, B. Biologie-cellulaire-emmanuelle, . Communication, B. Santé-isabelle et al., Chimie thérapeutique Chimie thérapeutique

F. Adel, F. Biophysique-acoustique-luc, G. Stéphane, H. Pharmacie-clinique-thierry, J. Chimie-organique-frédéric et al., Biophysique, Informatique Christine PERDICAKIS ........................ Chimie organique Caroline PERRIN-SARRADO ................. Pharmacologie Virginie PICHON

S. Anne, S. Pharmacie-galénique-marie-paule, B. Mycologie, T. Nathalie, T. Santé-publique-gabriel et al., Pharmacie galénique PROFESSEUR ASSOCIE, Biochimie et Biologie moléculaire Colette ZINUTTI

B. 1. Organe, . De-controle-des, and . Stupefiants, Rapport annuel pour, Disponible sur, 2006.

O. International, D. Controle, and . Stupefiants, Disponible sur : <http://www.incb.org, 2009.

O. International, D. Controle, and . Stupefiants, Communiqués de presse, Disponible sur, 2007.

H. Autorite and D. Sante, Synthèse d'avis de la commission de transparence : INSTANYL (fentanyl par voie nasale), opioïde Disponible sur : <http://www.has-sante.fr/portail, p.8, 2010.

C. Medicament, Thériaque : banque de données sur le médicament, [en ligne] Disponible sur, 2010.

O. Des-pharmaciens, Médicaments à dispensation particulière (MEDDISPAR) : Les substances vénéneuses - Médicaments stupéfiants et assimilés Disponible sur : <http://www.meddispar.fr/categories/les_substances_veneneuses/medicaments_stupefiants_et _assimiles>, p.5, 2010.

. Pr, D. Allain-hervé, D. Schück-stéphane, . Elizabeth, . Olivier et al., Les récepteurs aux opiacés. Mis à jour le 27 août, Disponible sur, 1999.

F. Nationale, D. De, L. Contre, and . Cancer, Standards, Options et Recommandations 2002 sur les traitements antalgiques médicamenteux des douleurs cancéreuses par excès de nociception chez l'adulte, p. 67 et tableau p. 76 ; 1996, mise à jour septembre, Disponible sur, 2002.

L. G. , S. B. Mallaret-m, and . L. Villard-m, Nouveaux antalgiques de niveau III de l'Organisation Mondiale de la Santé, Rev Med Interne, vol.23, issue.1, pp.55-70, 2002.

M. K. Tharratt-r and M. N. , Fentanyl remaining in a transdermal system following three days of continuous use

M. A. Osselton-m and . Widdop-b, Clarke's Analysis of Drugs and Poisons

M. L. Llorca-p, Les modalités de consommation : de l'usage à la dépendance. Annales médico-psychologiques, pp.439-442, 2007.

C. De, P. De-grenoble, and . Neurobiologie, Disponible sur : <http://www.centres-pharmacodependance.net/grenoble, Neurobio.htm>, p.8, 2009.

. Le-cerveau-À-tous-les-niveaux, Les centres du plaisir. [en ligne] Disponible sur, 2009.

O. Mondiale-de and L. Sante, RESUME -Neurosciences : usage de substances psychoactives et dépendance, Disponible sur, 2004.

M. Interministérielle-de-lutte-contre-la-drogue and . La-toxicomanie, MILDT) et Comité Français d'Éducation pour la Santé (CFES) Comprendre l'action des drogues, Disponible sur, 1999.

. Le-cerveau-À-tous-les-niveaux, Le rôle de la dopamine. [en ligne] Disponible sur, 2009.

N. And and B. University, Conditioned Place Preference Protocol. last update 19/03, Disponible sur, 2007.

L. P. Binsinger-c, Les médicaments détournés AFSSAPS, Plaquette d'information : Le réseau des CEIP AFSSAPS, Rapport d'activité 2006 : Bilan scientifique, Disponible sur, 2003.

O. International, D. Controle, and . Stupefiants, Communiqués de presse n°4 2005 : Les pharmacies sur internet font grimper les ventes de drogues illicites Disponible sur : <http://www.incb.org/pdf, pp.2005-2008, 2005.

O. International, D. Controle, and . Stupefiants, Rapport annuel pour, Disponible sur, 2004.

O. International, D. Controle, and . Stupefiants, Communiqués de presse, Disponible sur, 2006.

O. International, D. Controle, and . Stupefiants, Communiqués de presse, Disponible sur, 2008.

O. International, D. Controle, and . Stupefiants, Rapport annuel pour Disponible sur : <http://www.incb.org/pdf/annual-report, 2007.

O. International, D. Controle, and . Stupefiants, Disponible sur :. <http, 2009.

4. National, . On, and . Abuse, Last updated on wednesday, Disponible sur, 2008.

. Dr, . V. Gibaja, . Pr, and . H. Lambert, Potentiel d'abus et de dépendance d'Actiq®. Point sur les risques toxique et addictif, Commission Nationale des Stupéfiants et des Psychotropes, vol.21, p.7, 2008.

C. F. , L. H. Niemegeers-c, and . A. Janssen-p, Investigations on drug produced and subjectively experienced discriminative stimuli. I. The fentanyl cue, a tool to investigate subjectively experience narcotic drug actions, Life Sci, issue.5, pp.16-705, 1975.

R. J. Van, S. J. De, and W. D. , Intravenous self-administration of drugs in rats

F. C. Gerak-l, F. D. Winger-g, . Medzihradsky-f, . R. Bagley-j, . L. Brockunier-l et al., Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys, J Pharmacol Exp Ther, issue.1, pp.274-291, 1995.

F. V. Mafrica-f and . B. Santamaria-l, Killer fentanyl: a lesson from anaesthesiology, Lancet, vol.368, issue.9543, pp.1237-1245, 2006.

P. F. Mcauliffe, . S. Gold-m, M. M. Bajpai-l, P. R. Frost-pineda-k, G. B. Melker-r et al., Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons, Medical Hypotheses, vol.66, issue.5, pp.66-874, 2006.
DOI : 10.1016/j.mehy.2005.10.030

H. J. and P. J. Winek-c, An outbreak of designer drug--related deaths in Pennsylvania, JAMA, issue.8, pp.265-1011, 1991.

M. M. , H. J. , C. R. Frye-j, J. D. Lucid-e, and . Harchelroad-f, China White epidemic: an eastern United States emergency department experience

J. M. Desio, . R. Bacon-d, . Peer-g, and . J. Lema-m, Intravenous Abuse of Transdermal Fentanyl Therapy in a Chronic Pain Patient, Anesthesiology, vol.79, issue.5, pp.79-1139, 1993.
DOI : 10.1097/00000542-199311000-00036

S. J. Levine-b, C. L. Wu-s, and . J. Jenkins-a, A fentanyl epidemic in Maryland 1992, J Forensic Sci, vol.39, issue.1, pp.159-64, 1994.

F. S. Snenghi-r and . Tedeshi-l, Fatality due to fentanyl-cocaïne intoxication resulting in a fall, Int. J. Legal Med, vol.106, issue.5, pp.271-273, 1994.

F. L. Butts-j and A. W. , Fentanyl patches left on dead bodies --potential source of drug for abusers, J Forensic Sci, issue.2, pp.41-320, 1996.

K. R. , D. H. Holmgren-p, and R. J. , A cluster of fentanyl-related deaths among drug addicts in Sweden, Forensic Sci Int, vol.88, issue.3, pp.185-93, 1997.

K. C. Tawney-m, A fatal overdose of transdermally administered fentanyl, J Am Osteopath Assoc, issue.7, pp.98-385, 1998.

G. Jf and R. S. Schmidt-c, Lethal consequences following oral abuse of a fentanyl transdermal patch, 2000.

R. M. Ginifer-c, Fatal intravenous misuse of transdermal fentanyl

A. M. Satonik-r, Transdermal Fentanyl abuse and misuse, Am. J. Emerg. Med. On line, 1920.

K. J. Jr, . Mccaulley-r, . J. Valouch-t, and . S. Behonick-g, Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases, J Anal Toxicol, issue.7, pp.27-499, 2003.

T. A. Winecker-r and W. D. , Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches

L. P. , M. L. Bachs-l, and . Morild-i, Deaths after intravenous misuse of transdermal fentanyl, J Forensic Sci, issue.6, pp.49-1364, 2004.

G. V. Batt-a.-m and L. H. , Fentanyl : Détournement et Abus ? Etats des lieux, 2006.

M. T. Woodall-k and B. A. Mclellan, Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases, 2002.

W. S. Mundy-l, D. R. , C. J. , and W. W. , The Prevalence of Fentanyl in Drug-Related Deaths in Philadelphia, 2004.

H. M. , J. M. Mazur, F. , and F. M. Behonick-g, Fatalities associated with fentanyl and co-administered cocaine or opiates, J Forensic Sci, issue.6, pp.52-1383, 2007.

W. K. , M. T. Mclellan, and B. A. , Oral abuse of fentanyl patches (Duragesic): seven case reports, J Forensic Sci, vol.53, issue.1, pp.222-227, 2008.

S. H. Erickson-t, Z. M. Thompson-t, and . S. Denton-j, Fentanyl epidemic in Chicago, Illinois and surrounding Cook County Clin Toxicol (Phila), pp.46-501, 2008.

C. H. Knight-l and D. M. Garg-u, A fatality involving an unusual route of fentanyl delivery: Chewing and aspirating the transdermal patch, Leg Med, 2010.

W. C. and W. G. Saidman-l, Drug abuse in anesthesia training programs. A survey: 1970 through 1980, JAMA, issue.7, pp.250-922, 1983.

P. E. , M. J. Gault-r, and M. H. , A death involving fentanyl, J Anal Toxicol, issue.116, pp.272-277, 1987.

L. B. Goodin-j and C. Y. , A fentanyl fatality involving midazolam, Forensic Sci Int, vol.45, issue.3, pp.247-51, 1990.

K. P. Villain-m and C. V. Dumestre-v, Evidence of addiction by anesthesiologists as documented by hair analysis, Forensic Sci Int, vol.153, issue.1, pp.81-85, 2005.

T. M. Watts-d, M. H. , P. J. , and S. J. , Fentanyl-laced heroin : a report from an

B. J. Grossman-d, M. J. Lineberger-c, R. J. , R. J. , and S. D. , Substance abuse among physicians: a survey of academic anesthesiology programs, Anesth Analg, vol.95, issue.4, pp.1024-1054, 2002.

M. S. Gold-m, . A. Byars-j, and . Frost-pineda-k, Occupational exposure and addictions for physicians: case studies and theoretical implications, Psychiatric Clinics of North America, vol.27, issue.4, pp.745-53, 2004.
DOI : 10.1016/j.psc.2004.07.006

G. M. Melker-r, D. D. Morey, T. E. Bajpai-l, and P. R. Frost-pineda-k, Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis, J Addict Dis, issue.1, pp.25-40, 2006.

B. F. Jr, . A. Howland-m, and N. S. Hoffman-r, The fentanyl tea bag, Vet Hum Toxicol, vol.46, issue.1, pp.30-31, 2004.

L. I. Dimopoulos-n, . Mellos-e, L. E. Gitsa-o, and R. A. , Oral transmucosal abuse of transdermal fentanyl, J Psychopharmacol, vol.18, issue.2, pp.277-80, 2004.

I. C. , K. H. , C. M. Minouchi-t, and Y. A. Endo-y, Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg, Pharm World Sci, vol.27, issue.1, pp.13-18, 2005.

C. For, . Organizations, . Medical, and . Cioms, Suspect adverse reaction report. -Mfr. Control No 11 mars, p.2010001220, 2010.

G. Suneel, K. Durogesic®, and D. , nouveau système de délivrance du fentanyl par matrice: les progrès d'une nouvelle technologie. Douleurs, pp.105-108, 2005.

R. A. , R. N. , R. J. Ch, R. S. , and R. J. Sztark-f, Evaluation du dispositif transdermique d'administration de fentanyl (Ionsys®) dans l'analgésie après chirurgie urologique. Revue d'anesthésie-Réanimation et de Médecine, pp.1-4, 2009.

L. Redaction and D. Prescrire, Fentanyl en patchs : surdoses évitables, pp.747-750, 2009.

G. J. Koczmara-c, . Cheng-r, and . Hyland-s, Safety issues with fentanyl patches require pharmaceutical care, CJHP, issue.1, pp.61-57, 2008.

1. United and . Pharmacopeia, Preventable dangers associated with fentanyl patches. USP Patient Safety-Capslink(TM), p.11, 2007.

H. W. Jr and K. W. Palmisano-p, Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch, South Med J, issue.9, pp.90-962, 1997.

R. B. Morawiecka-i, Transdermal fentanyl (Duragesic): respiratory arrest in adolescents, CMAJ, vol.171, issue.8, pp.991-993, 2004.

I. For, . Medication, and . Practices, Medical Safety Alert : Child dies from misuse of fentanyl patch Disponible sur: <http://www.ismp.org/Newsletters, p.5, 2008.

R. R. Van and G. C. Van, A delirious patient with opioid intoxication after chewing a fentanyl patch, J Am Geriatr Soc, issue.8, pp.54-1298, 2006.

H. P. and M. L. Wadelius-m, Possible fluconazole-fentanyl interaction-a case report

B. M. Mallaret-m and C. A. Richard-n, Plan de gestion des risques : aspects spécifiques de la pharmacodépendance

A. Psychiatric-association and D. Iv-tr, Diagnostic and Statistical Manual, Fourth Edition, Text Revision, 2000.

O. Mondiale-de and L. Sante, RESUME -Neurosciences : usage de substances psychoactives et dépendance, Disponible sur, pp.18-19, 2004.